SCHEMBL12871191

SCHEMBL12871191

COC(=O)C(Cc1ccc(O)cc1)NC(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.58
ESR2 Q92731 1/20 0.58
TSHR P16473 1/20 0.56
NPSR1 Q6W5P4 2/20 0.54
KMT2A Q03164 1/20 0.54
LNPEP Q9UIQ6 3/20 0.53
MDM4 O15151 1/20 0.53
MDM2 Q00987 1/20 0.53
NLRP3 Q96P20 1/20 0.52
MIF P14174 1/20 0.50
FOLH1 Q04609 1/20 0.48
ALDH1A1 P00352 2/20 0.47
ELANE P08246 1/20 0.47
THRB P10828 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HSD17B10 Q99714 1/20 0.47
KDR P35968 1/20 0.46
ANPEP P15144 1/20 0.46
ERAP2 Q6P179 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25453645 0.87 ATM (0.56) ESR1ESR2TSHRNPSR1KMT2A
SCHEMBL20850491 0.86 LDHA (0.54) TSHRALDH1A1
SCHEMBL12871196 0.86 NOS2 (0.52) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL16252284 0.85 ALDH1A1 (0.62) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL13532075 0.85 ALDH1A1 (0.62) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL25453629 0.85 ALDH1A1 (0.62) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL20988044 0.84 ESR1 (0.55) ESR1ESR2TSHRNPSR1KMT2A
SCHEMBL12869808 0.83 FOLH1 (0.61) KMT2AFOLH1
SCHEMBL24445702 0.83 ESR1 (0.61) ESR1ESR2TSHRNPSR1KMT2A
SCHEMBL5614085 0.83 ESR1 (0.61) ESR1ESR2TSHRNPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017535-A1 INHIBITORS OF ALDOSE REDUCTASE BARCLAYS BANK PLC (GB) 2022-01-20 US disclosed
WO-2021202600-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ THE SCRIPPS RESEARCH INSTITUTE (US) 2021-10-07 WO disclosed
US-10246478-B2 Polyene macrolide derivative SHIONOGI & CO., LTD. (JP) 2019-04-02 US disclosed
US-20170190729-A1 POLYENE MACROLIDE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2017-07-06 US disclosed
US-7888363-B2 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-02-15 US disclosed
US-20070142380-A1 Viral Polymerase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 US disclosed
US-20070142380-A1 Viral Polymerase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 US disclosed
US-7223785-B2 Viral polymerase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190729-A1 POLYENE MACROLIDE DERIVATIVE ERG28, RPL23, RPL10 ESR1 4776/4885ESR2 4568/4885TSHR 4491/4885
US-10246478-B2 Polyene macrolide derivative ERG28, RPL23, RPL10 ESR1 4776/4885ESR2 4568/4885TSHR 4491/4885
US-20220017535-A1 INHIBITORS OF ALDOSE REDUCTASE PMM2, DPM1, BPGM ESR1 2259/4885ESR2 1729/4885TSHR 3977/4885
US-20070142380-A1 Viral Polymerase Inhibitors POLM, POLR2H, POLR2A ESR1 2403/4885ESR2 3431/4885TSHR 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.